SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001842952-23-000015
Filing Date
2023-02-06
Accepted
2023-02-06 07:31:55
Documents
55
Period of Report
2023-02-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cntx-20230206.htm   iXBRL 8-K 35870
2 EX-99.1 cntxpressreleasefeb62023.htm EX-99.1 27192
3 EX-99.2 a2023feb_contextxcorppre.htm EX-99.2 51389
7 a2023feb_contextxcorppre001.jpg GRAPHIC 57026
8 a2023feb_contextxcorppre002.jpg GRAPHIC 241586
9 a2023feb_contextxcorppre003.jpg GRAPHIC 127901
10 a2023feb_contextxcorppre004.jpg GRAPHIC 94877
11 a2023feb_contextxcorppre005.jpg GRAPHIC 98912
12 a2023feb_contextxcorppre006.jpg GRAPHIC 68598
13 a2023feb_contextxcorppre007.jpg GRAPHIC 155659
14 a2023feb_contextxcorppre008.jpg GRAPHIC 129904
15 a2023feb_contextxcorppre009.jpg GRAPHIC 137993
16 a2023feb_contextxcorppre010.jpg GRAPHIC 129491
17 a2023feb_contextxcorppre011.jpg GRAPHIC 106909
18 a2023feb_contextxcorppre012.jpg GRAPHIC 107286
19 a2023feb_contextxcorppre013.jpg GRAPHIC 92095
20 a2023feb_contextxcorppre014.jpg GRAPHIC 109176
21 a2023feb_contextxcorppre015.jpg GRAPHIC 130737
22 a2023feb_contextxcorppre016.jpg GRAPHIC 108709
23 a2023feb_contextxcorppre017.jpg GRAPHIC 141920
24 a2023feb_contextxcorppre018.jpg GRAPHIC 84022
25 a2023feb_contextxcorppre019.jpg GRAPHIC 69107
26 a2023feb_contextxcorppre020.jpg GRAPHIC 70618
27 a2023feb_contextxcorppre021.jpg GRAPHIC 127383
28 a2023feb_contextxcorppre022.jpg GRAPHIC 92843
29 a2023feb_contextxcorppre023.jpg GRAPHIC 106121
30 a2023feb_contextxcorppre024.jpg GRAPHIC 113315
31 a2023feb_contextxcorppre025.jpg GRAPHIC 68796
32 a2023feb_contextxcorppre026.jpg GRAPHIC 141569
33 a2023feb_contextxcorppre027.jpg GRAPHIC 104425
34 a2023feb_contextxcorppre028.jpg GRAPHIC 106740
35 a2023feb_contextxcorppre029.jpg GRAPHIC 117661
36 a2023feb_contextxcorppre030.jpg GRAPHIC 67793
37 a2023feb_contextxcorppre031.jpg GRAPHIC 68462
38 a2023feb_contextxcorppre032.jpg GRAPHIC 121075
39 a2023feb_contextxcorppre033.jpg GRAPHIC 106164
40 a2023feb_contextxcorppre034.jpg GRAPHIC 118684
41 a2023feb_contextxcorppre035.jpg GRAPHIC 100418
42 a2023feb_contextxcorppre036.jpg GRAPHIC 63796
43 a2023feb_contextxcorppre037.jpg GRAPHIC 89962
44 a2023feb_contextxcorppre038.jpg GRAPHIC 65013
45 a2023feb_contextxcorppre039.jpg GRAPHIC 56337
46 a2023feb_contextxcorppre040.jpg GRAPHIC 104944
47 image_0.jpg GRAPHIC 198753
  Complete submission text file 0001842952-23-000015.txt   6358328

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20230206.xsd EX-101.SCH 1935
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20230206_lab.xml EX-101.LAB 26869
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20230206_pre.xml EX-101.PRE 14141
49 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20230206_htm.xml XML 11842
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40654 | Film No.: 23588375
SIC: 2834 Pharmaceutical Preparations